K192376

Substantially Equivalent

Simplexa VZV Swab Direct, Simplexa VZV Positive Control Pack

Applicant: Diasorin Molecular, LLC
Product code: PGI
Advisory panel: Microbiology
Date received: 2019-08-30
Decision date: 2019-11-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cypress, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.